Yvonne Mueller - Publications

Affiliations: 
Drexel University College of Medicine, Philadelphia, PA, United States 

60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Papagiannopoulos OD, Kourou K, Papaloukas C, Karanasiou GS, van de Werken HJG, Mueller YM, Katsikis PD, Herrero-Saboya D, Fotiadis DI. Classification of Inflammation of Unknown Origin patients based on RNA-seq and SomaScan data. Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual International Conference. 2023: 1-4. PMID 38083327 DOI: 10.1109/EMBC40787.2023.10340537  0.493
2023 Castro Eiro MD, Hioki K, Li L, Wilmsen MEP, Kiernan CH, Brouwers-Haspels I, van Meurs M, Zhao M, de Wit H, Grashof DGB, van de Werken HJG, Mueller YM, Schliehe C, Temizoz B, Kobiyama K, et al. TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model. Journal of Immunology (Baltimore, Md. : 1950). PMID 38063488 DOI: 10.4049/jimmunol.2300038  0.79
2023 Vietsch EE, Latifi D, Verheij M, van der Oost EWA, de Wilde RF, Haen R, van den Boom AL, Koerkamp BG, Doornebosch PG, van Verschuer VMT, Ooms AHAG, Mohammad F, Willemsen M, Aerts JGJV, Krog RT, ... ... Mueller YM, et al. B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients. Frontiers in Immunology. 14: 1230306. PMID 38022530 DOI: 10.3389/fimmu.2023.1230306  0.586
2023 Li L, Zhao M, Kiernan CH, Castro Eiro MD, van Meurs M, Brouwers-Haspels I, Wilmsen MEP, Grashof DGB, van de Werken HJG, Hendriks RW, Mueller YM, Katsikis PD. Ibrutinib directly reduces CD8+T cell exhaustion independent of BTK. Frontiers in Immunology. 14: 1201415. PMID 37771591 DOI: 10.3389/fimmu.2023.1201415  0.843
2023 Zhao M, Li L, Kiernan CH, Castro Eiro MD, Dammeijer F, van Meurs M, Brouwers-Haspels I, Wilmsen MEP, Grashof DGB, van de Werken HJG, Hendriks RW, Aerts JG, Mueller YM, Katsikis PD. Overcoming immune checkpoint blockade resistance in solid tumors with intermittent ITK inhibition. Scientific Reports. 13: 15678. PMID 37735204 DOI: 10.1038/s41598-023-42871-y  0.806
2023 Wahadat MJ, van Tilburg SJ, Mueller YM, de Wit H, Van Helden-Meeuwsen CG, Langerak AW, Gruijters MJ, Mubarak A, Verkaaik M, Katsikis PD, Versnel MA, Kamphuis S. Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study. Lupus Science & Medicine. 10. PMID 37012057 DOI: 10.1136/lupus-2022-000799  0.494
2023 Prins HAB, Crespo R, Lungu C, Rao S, Li L, Overmars RJ, Papageorgiou G, Mueller YM, Stoszko M, Hossain T, Kan TW, Rijnders BJA, Bax HI, van Gorp ECM, Nouwen JL, et al. The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy. Science Advances. 9: eade6675. PMID 36921041 DOI: 10.1126/sciadv.ade6675  0.538
2023 Hensley KS, Jongkees MJ, Geers D, GeurtsvanKessel CH, Mueller YM, Dalm VASH, Papageorgiou G, Steggink H, Gorska A, Bogers S, den Hollander JG, Bierman WFW, Gelinck LBS, Schippers EF, Ammerlaan HSM, et al. Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study. Plos Medicine. 20: e1004159. PMID 36608645 DOI: 10.1371/journal.pmed.1004159  0.514
2022 Jongkees MJ, Geers D, Hensley KS, Huisman W, GeurtsvanKessel CH, Bogers S, Gommers L, Papageorgiou G, Jochems SP, den Hollander JG, Schippers EF, Ammerlaan HSM, Bierman WFW, van der Valk M, Berrevoets MAH, ... ... Mueller YM, et al. Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people with HIV with hyporesponse after primary vaccination. The Journal of Infectious Diseases. PMID 36402141 DOI: 10.1093/infdis/jiac451  0.519
2022 Hensley KS, Jongkees MJ, Geers D, GeurtsvanKessel CH, Mueller YM, Dalm VASH, Papageorgiou G, Steggink H, Gorska A, Bogers S, den Hollander JG, Bierman WFW, Gelinck LBS, Schippers EF, Ammerlaan HSM, et al. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study. Plos Medicine. 19: e1003979. PMID 36301821 DOI: 10.1371/journal.pmed.1003979  0.505
2022 Mueller YM, Schrama TJ, Ruijten R, Schreurs MWJ, Grashof DGB, van de Werken HJG, Lasinio GJ, Álvarez-Sierra D, Kiernan CH, Castro Eiro MD, van Meurs M, Brouwers-Haspels I, Zhao M, Li L, de Wit H, et al. Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning. Nature Communications. 13: 915. PMID 35177626 DOI: 10.1038/s41467-022-28621-0  0.751
2022 Hope JL, Zhao M, Stairiker CJ, Kiernan CH, Carey AJ, Mueller YM, van Meurs M, Brouwers-Haspels I, Otero DC, Bae EA, Faso HA, Maas A, de Looper H, Fortina PM, Rigoutsos I, et al. MicroRNA-139 Expression Is Dispensable for the Generation of Influenza-Specific CD8 T Cell Responses. Journal of Immunology (Baltimore, Md. : 1950). 208: 603-617. PMID 35022277 DOI: 10.4049/jimmunol.2000621  0.795
2021 Gharbharan A, Jordans CCE, GeurtsvanKessel C, den Hollander JG, Karim F, Mollema FPN, Stalenhoef-Schukken JE, Dofferhoff A, Ludwig I, Koster A, Hassing RJ, Bos JC, van Pottelberge GR, Vlasveld IN, Ammerlaan HSM, ... ... Mueller YM, et al. Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection. Nature Communications. 12: 3189. PMID 34045486 DOI: 10.1038/s41467-021-23469-2  0.509
2021 Rao S, Lungu C, Crespo R, Steijaert TH, Gorska A, Palstra RJ, Prins HAB, van Ijcken W, Mueller YM, van Kampen JJA, Verbon A, Katsikis PD, Boucher CAB, Rokx C, Gruters RA, et al. Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir. Nature Communications. 12: 2475. PMID 33931637 DOI: 10.1038/s41467-021-22608-z  0.674
2021 Erkeland SJ, Stavast CJ, Schilperoord-Vermeulen J, Dal Collo G, Van de Werken HJG, Leon LG, Van Hoven-Beijen A, Van Zuijen I, Mueller YM, Bindels EM, De Ridder D, Kappers-Klunne MC, Van Lom K, Van der Velden VHJ, Langerak AW. The miR-200c/141-ZEB2-TGFβ axis is aberrant in human T-cell prolymphocytic leukemia. Haematologica. PMID 33596640 DOI: 10.3324/haematol.2020.263756  0.335
2020 Dammeijer F, van Gulijk M, Mulder EE, Lukkes M, Klaase L, van den Bosch T, van Nimwegen M, Lau SP, Latupeirissa K, Schetters S, van Kooyk Y, Boon L, Moyaart A, Mueller YM, Katsikis PD, et al. The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes. Cancer Cell. PMID 33007259 DOI: 10.1016/j.ccell.2020.09.001  0.536
2020 Stoszko M, Al-Hatmi AMS, Skriba A, Roling M, Ne E, Crespo R, Mueller YM, Najafzadeh MJ, Kang J, Ptackova R, LeMasters E, Biswas P, Bertoldi A, Kan TW, de Crignis E, et al. Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency. Science Advances. 6: eaba6617. PMID 32851167 DOI: 10.1126/Sciadv.Aba6617  0.625
2020 Stairiker CJ, van Meurs M, Leon LG, Brouwers-Haspels AA, Rijsbergen L, Mueller YM, Katsikis PD. Heatr9 is an infection responsive gene that affects cytokine production in alveolar epithelial cells. Plos One. 15: e0236195. PMID 32678841 DOI: 10.1371/Journal.Pone.0236195  0.79
2020 Zhao M, Kiernan CH, Stairiker CJ, Hope JL, Leon LG, van Meurs M, Brouwers-Haspels I, Boers R, Boers J, Gribnau J, van IJcken WFJ, Bindels EM, Hoogenboezem RM, Erkeland SJ, Mueller YM, et al. Rapid in vitro generation of bona fide exhausted CD8+ T cells is accompanied by Tcf7 promotor methylation. Plos Pathogens. 16: e1008555. PMID 32579593 DOI: 10.1371/Journal.Ppat.1008555  0.806
2019 Hope JL, Spantidea PI, Kiernan CH, Stairiker CJ, Rijsbergen LC, van Meurs M, Brouwers-Haspels I, Mueller YM, Nelson DJ, Bradley LM, Aerts JGJV, Katsikis PD. Microenvironment-Dependent Gradient of CTL Exhaustion in the AE17sOVA Murine Mesothelioma Tumor Model. Frontiers in Immunology. 10: 3074. PMID 31998326 DOI: 10.3389/Fimmu.2019.03074  0.796
2018 Zhao M, De Crignis E, Rokx C, Verbon A, van Gelder T, Mahmoudi T, Katsikis PD, Mueller YM. T cell toxicity of HIV latency reversing agents. Pharmacological Research. PMID 30366100 DOI: 10.1016/J.Phrs.2018.10.023  0.851
2018 Hancock AS, Stairiker CJ, Boesteanu AC, Monzón-Casanova E, Lukasiak S, Mueller YM, Stubbs AP, Garcia-Sastre A, Turner M, Katsikis PD. Transcriptome analysis of infected and bystander type 2 alveolar epithelial cells during influenza A virus infection reveals Wnt pathway downregulation. Journal of Virology. PMID 30111569 DOI: 10.1128/Jvi.01325-18  0.791
2018 Wentink MWJ, Mueller YM, Dalm VASH, Driessen GJ, van Hagen PM, van Montfrans JM, van der Burg M, Katsikis PD. Exhaustion of the CD8T Cell Compartment in Patients with Mutations in Phosphoinositide 3-Kinase Delta. Frontiers in Immunology. 9: 446. PMID 29563914 DOI: 10.3389/Fimmu.2018.00446  0.675
2018 Palstra RJ, de Crignis E, Röling MD, van Staveren T, Kan TW, van Ijcken W, Mueller YM, Katsikis PD, Mahmoudi T. Allele-specific long-distance regulation dictates IL-32 isoform switching and mediates susceptibility to HIV-1. Science Advances. 4: e1701729. PMID 29507875 DOI: 10.1126/Sciadv.1701729  0.562
2017 Hope JL, Stairiker CJ, Spantidea PI, Gracias DT, Carey AJ, Fike AJ, van Meurs M, Brouwers-Haspels I, Rijsbergen LC, Fraietta JA, Mueller YM, Klop RC, Stelekati E, Wherry EJ, Erkeland SJ, et al. The Transcription Factor T-Bet Is Regulated by MicroRNA-155 in Murine Anti-Viral CD8+ T Cells via SHIP-1. Frontiers in Immunology. 8: 1696. PMID 29358931 DOI: 10.3389/Fimmu.2017.01696  0.793
2017 Carey AJ, Hope JL, Mueller YM, Fike AJ, Kumova OK, van Zessen DBH, Steegers EAP, van der Burg M, Katsikis PD. Public Clonotypes and Convergent Recombination Characterize the Naïve CD8+ T-Cell Receptor Repertoire of Extremely Preterm Neonates. Frontiers in Immunology. 8: 1859. PMID 29312340 DOI: 10.3389/Fimmu.2017.01859  0.814
2016 Carey AJ, Gracias DT, Thayer JL, Boesteanu AC, Kumova OK, Mueller YM, Hope JL, Fraietta JA, van Zessen DB, Katsikis PD. Rapid Evolution of the CD8+ TCR Repertoire in Neonatal Mice. Journal of Immunology (Baltimore, Md. : 1950). PMID 26873987 DOI: 10.4049/Jimmunol.1502126  0.815
2016 Gracias DT, Boesteanu AC, Fraietta JA, Hope JL, Carey AJ, Mueller YM, Kawalekar OU, Fike AJ, June CH, Katsikis PD. Phosphatidylinositol 3-Kinase p110δ Isoform Regulates CD8+ T Cell Responses during Acute Viral and Intracellular Bacterial Infections. Journal of Immunology (Baltimore, Md. : 1950). PMID 26740110 DOI: 10.4049/Jimmunol.1501890  0.827
2014 Johnson BM, Fraietta JA, Gracias DT, Hope JL, Stairiker CJ, Patel PR, Mueller YM, McHugh MD, Jablonowski LJ, Wheatley MA, Katsikis PD. Acute exposure to ZnO nanoparticles induces autophagic immune cell death. Nanotoxicology. 1-12. PMID 25378273 DOI: 10.3109/17435390.2014.974709  0.74
2014 Fraietta JA, Mueller YM, Lozenski KL, Ratner D, Boesteanu AC, Hancock AS, Lackman-Smith C, Zentner IJ, Chaiken IM, Chung S, LeGrice SF, Snyder BA, Mankowski MK, Jones NM, Hope JL, et al. Abasic phosphorothioate oligomers inhibit HIV-1 reverse transcription and block virus transmission across polarized ectocervical organ cultures. Antimicrobial Agents and Chemotherapy. 58: 7056-71. PMID 25224013 DOI: 10.1128/Aac.02991-14  0.782
2013 Fraietta JA, Mueller YM, Yang G, Boesteanu AC, Gracias DT, Do DH, Hope JL, Kathuria N, McGettigan SE, Lewis MG, Giavedoni LD, Jacobson JM, Katsikis PD. Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection. Plos Pathogens. 9: e1003658. PMID 24130482 DOI: 10.1371/Journal.Ppat.1003658  0.842
2013 Gracias DT, Stelekati E, Hope JL, Boesteanu AC, Doering TA, Norton J, Mueller YM, Fraietta JA, Wherry EJ, Turner M, Katsikis PD. The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling. Nature Immunology. 14: 593-602. PMID 23603793 DOI: 10.1038/Ni.2576  0.826
2011 Katsikis PD, Mueller YM, Villinger F. The cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point? Plos Pathogens. 7: e1002055. PMID 21852945 DOI: 10.1371/Journal.Ppat.1002055  0.576
2011 Lugli E, Mueller YM, Lewis MG, Villinger F, Katsikis PD, Roederer M. IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques. Blood. 118: 2520-9. PMID 21757617 DOI: 10.1182/Blood-2011-05-351155  0.723
2011 Dolfi DV, Duttagupta PA, Boesteanu AC, Mueller YM, Oliai CH, Borowski AB, Katsikis PD. Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo. Journal of Immunology (Baltimore, Md. : 1950). 186: 4599-608. PMID 21389258 DOI: 10.4049/Jimmunol.1001972  0.841
2010 Mueller YM, Katsikis PD. IL-15 in HIV infection: pathogenic or therapeutic potential? European Cytokine Network. 21: 219-21. PMID 20719708 DOI: 10.1684/Ecn.2010.0198  0.643
2010 Fraietta JA, Mueller YM, Do DH, Holmes VM, Howett MK, Lewis MG, Boesteanu AC, Alkan SS, Katsikis PD. Phosphorothioate 2' deoxyribose oligomers as microbicides that inhibit human immunodeficiency virus type 1 (HIV-1) infection and block Toll-like receptor 7 (TLR7) and TLR9 triggering by HIV-1. Antimicrobial Agents and Chemotherapy. 54: 4064-73. PMID 20625151 DOI: 10.1128/Aac.00367-10  0.741
2009 Mueller YM, Do DH, Boyer JD, Kader M, Mattapallil JJ, Lewis MG, Weiner DB, Katsikis PD. CD8+ cell depletion of SHIV89.6P-infected macaques induces CD4+ T cell proliferation that contributes to increased viral loads. Journal of Immunology (Baltimore, Md. : 1950). 183: 5006-12. PMID 19786539 DOI: 10.4049/Jimmunol.0900141  0.729
2009 Petrovas C, Chaon B, Ambrozak DR, Price DA, Melenhorst JJ, Hill BJ, Geldmacher C, Casazza JP, Chattopadhyay PK, Roederer M, Douek DC, Mueller YM, Jacobson JM, Kulkarni V, Felber BK, et al. Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. Journal of Immunology (Baltimore, Md. : 1950). 183: 1120-32. PMID 19564339 DOI: 10.4049/Jimmunol.0900182  0.671
2009 Bucks CM, Norton JA, Boesteanu AC, Mueller YM, Katsikis PD. Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion. Journal of Immunology (Baltimore, Md. : 1950). 182: 6697-708. PMID 19454664 DOI: 10.4049/Jimmunol.0800997  0.845
2009 Eberly MD, Kader M, Hassan W, Rogers KA, Zhou J, Mueller YM, Mattapallil MJ, Piatak M, Lifson JD, Katsikis PD, Roederer M, Villinger F, Mattapallil JJ. Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection. Journal of Immunology (Baltimore, Md. : 1950). 182: 1439-48. PMID 19155491 DOI: 10.4049/Jimmunol.182.3.1439  0.699
2008 Elbim C, Monceaux V, Mueller YM, Lewis MG, François S, Diop O, Akarid K, Hurtrel B, Gougerot-Pocidalo MA, Lévy Y, Katsikis PD, Estaquier J. Early divergence in neutrophil apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates. Journal of Immunology (Baltimore, Md. : 1950). 181: 8613-23. PMID 19050281 DOI: 10.4049/Jimmunol.181.12.8613  0.566
2008 Mueller YM, Do DH, Altork SR, Artlett CM, Gracely EJ, Katsetos CD, Legido A, Villinger F, Altman JD, Brown CR, Lewis MG, Katsikis PD. IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 180: 350-60. PMID 18097036 DOI: 10.4049/Jimmunol.180.1.350  0.687
2007 Borowski AB, Boesteanu AC, Mueller YM, Carafides C, Topham DJ, Altman JD, Jennings SR, Katsikis PD. Memory CD8+ T cells require CD28 costimulation. Journal of Immunology (Baltimore, Md. : 1950). 179: 6494-503. PMID 17982038 DOI: 10.4049/Jimmunol.179.10.6494  0.724
2007 Petrovas C, Mueller YM, Yang G, Altork SR, Jacobson JM, Pitsakis PG, Mounzer KC, Altman JD, Katsikis PD. Actin integrity is indispensable for CD95/Fas-induced apoptosis of HIV-specific CD8+ T cells. Apoptosis : An International Journal On Programmed Cell Death. 12: 2175-86. PMID 17891455 DOI: 10.1007/S10495-007-0128-Y  0.698
2007 Mueller YM, Petrovas C, Do DH, Altork SR, Fischer-Smith T, Rappaport J, Altman JD, Lewis MG, Katsikis PD. Early establishment and antigen dependence of simian immunodeficiency virus-specific CD8+ T-cell defects. Journal of Virology. 81: 10861-8. PMID 17670818 DOI: 10.1128/Jvi.00813-07  0.724
2007 Petrovas C, Mueller YM, Dimitriou ID, Altork SR, Banerjee A, Sklar P, Mounzer KC, Altman JD, Katsikis PD. Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8(+) T cells. Blood. 109: 2505-13. PMID 17095625 DOI: 10.1182/Blood-2006-05-021626  0.696
2005 Petrovas C, Mueller YM, Katsikis PD. Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy. Cell Death and Differentiation. 12: 859-70. PMID 15818412 DOI: 10.1038/Sj.Cdd.4401595  0.679
2005 Mueller YM, Petrovas C, Bojczuk PM, Dimitriou ID, Beer B, Silvera P, Villinger F, Cairns JS, Gracely EJ, Lewis MG, Katsikis PD. Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques. Journal of Virology. 79: 4877-85. PMID 15795273 DOI: 10.1128/Jvi.79.8.4877-4885.2005  0.702
2005 Naguib NN, Mueller YM, Bojczuk PM, Rossi MP, Katsikis PD, Gogotsi Y. Effect of carbon nanofibre structure on the binding of antibodies Nanotechnology. 16: 567-571. DOI: 10.1088/0957-4484/16/4/038  0.494
2004 Kim AH, Dimitriou ID, Holland MC, Mastellos D, Mueller YM, Altman JD, Lambris JD, Katsikis PD. Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 173: 2524-9. PMID 15294968 DOI: 10.4049/Jimmunol.173.4.2524  0.793
2004 Petrovas C, Mueller YM, Katsikis PD. HIV-specific CD8+ T cells: serial killers condemned to die? Current Hiv Research. 2: 153-62. PMID 15078179 DOI: 10.2174/1570162043484960  0.692
2004 Petrovas C, Mueller YM, Dimitriou ID, Bojczuk PM, Mounzer KC, Witek J, Altman JD, Katsikis PD. HIV-specific CD8+ T cells exhibit markedly reduced levels of Bcl-2 and Bcl-xL. Journal of Immunology (Baltimore, Md. : 1950). 172: 4444-53. PMID 15034060 DOI: 10.4049/Jimmunol.172.7.4444  0.714
2003 Maldonado A, Mueller YM, Thomas P, Bojczuk P, O'Connors C, Katsikis PD. Decreased effector memory CD45RA+ CD62L- CD8+ T cells and increased central memory CD45RA- CD62L+ CD8+ T cells in peripheral blood of rheumatoid arthritis patients. Arthritis Research & Therapy. 5: R91-6. PMID 12718752 DOI: 10.1186/Ar619  0.672
2003 Mueller YM, Makar V, Bojczuk PM, Witek J, Katsikis PD. IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells. International Immunology. 15: 49-58. PMID 12502725 DOI: 10.1093/Intimm/Dxg013  0.701
2003 Mueller YM, Bojczuk PM, Halstead ES, Kim AH, Witek J, Altman JD, Katsikis PD. IL-15 enhances survival and function of HIV-specific CD8+ T cells. Blood. 101: 1024-9. PMID 12393488 DOI: 10.1182/Blood-2002-07-1957  0.837
2002 Halstead ES, Mueller YM, Altman JD, Katsikis PD. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nature Immunology. 3: 536-41. PMID 12021777 DOI: 10.1038/Ni798  0.82
2002 Xu H, Exner BG, Cramer DE, Tanner MK, Mueller YM, Ildstad ST. CD8(+), alphabeta-TCR(+), and gammadelta-TCR(+) cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow. Journal of Immunology (Baltimore, Md. : 1950). 168: 1636-43. PMID 11823491 DOI: 10.4049/jimmunol.168.4.1636  0.394
2001 Mueller YM, De Rosa SC, Hutton JA, Witek J, Roederer M, Altman JD, Katsikis PD. Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells. Immunity. 15: 871-82. PMID 11754810 DOI: 10.1016/S1074-7613(01)00246-1  0.719
2001 Cocca BA, Seal SN, D'Agnillo P, Mueller YM, Katsikis PD, Rauch J, Weigert M, Radic MZ. Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proceedings of the National Academy of Sciences of the United States of America. 98: 13826-31. PMID 11717440 DOI: 10.1073/Pnas.241510698  0.545
Show low-probability matches.